The global Decoagulant market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Decoagulant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Decoagulant is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Decoagulant include Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen and Lilly, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Decoagulant, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decoagulant.

Report Scope

The Decoagulant market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Decoagulant market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Decoagulant manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Decoagulant Market Report

Report Metric	Details
Report Name	Decoagulant Market
Segment by Type	Platelet Aggregation Inhibitors (PAI) Low-Molecular-Weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Direct Factor Xa Inhibitors (DFXa) Vitamin K Antagonists (VKA) Others
Segment by Application	VTE ACS/MI AF Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen, Lilly, Otsuka, Pfizer, Daiichi Sankyo, The Medicines Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Decoagulant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Decoagulant in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Decoagulant Market report?

Ans: The main players in the Decoagulant Market are Sanofi, Bayer, Boehringer Ingelheim, Johnson & Johnson, Genentech (Roche), AstraZeneca, Bristol-Myers Squibb, Aspen, Lilly, Otsuka, Pfizer, Daiichi Sankyo, The Medicines Company

What are the Application segmentation covered in the Decoagulant Market report?

Ans: The Applications covered in the Decoagulant Market report are VTE, ACS/MI, AF, Others

What are the Type segmentation covered in the Decoagulant Market report?

Ans: The Types covered in the Decoagulant Market report are Platelet Aggregation Inhibitors (PAI), Low-Molecular-Weight Heparin (LMWH), Direct Thrombin Inhibitor (DTI), Direct Factor Xa Inhibitors (DFXa), Vitamin K Antagonists (VKA), Others

1 Decoagulant Market Overview

1.1 Product Overview and Scope of Decoagulant

1.2 Decoagulant Segment by Type

1.2.1 Global Decoagulant Market Value Comparison by Type (2024-2030)

1.2.2 Platelet Aggregation Inhibitors (PAI)

1.2.3 Low-Molecular-Weight Heparin (LMWH)

1.2.4 Direct Thrombin Inhibitor (DTI)

1.2.5 Direct Factor Xa Inhibitors (DFXa)

1.2.6 Vitamin K Antagonists (VKA)

1.2.7 Others

1.3 Decoagulant Segment by Application

1.3.1 Global Decoagulant Market Value by Application: (2024-2030)

1.3.2 VTE

1.3.3 ACS/MI

1.3.4 AF

1.3.5 Others

1.4 Global Decoagulant Market Size Estimates and Forecasts

1.4.1 Global Decoagulant Revenue 2019-2030

1.4.2 Global Decoagulant Sales 2019-2030

1.4.3 Global Decoagulant Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Decoagulant Market Competition by Manufacturers

2.1 Global Decoagulant Sales Market Share by Manufacturers (2019-2024)

2.2 Global Decoagulant Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Decoagulant Average Price by Manufacturers (2019-2024)

2.4 Global Decoagulant Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Decoagulant, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Decoagulant, Product Type & Application

2.7 Decoagulant Market Competitive Situation and Trends

2.7.1 Decoagulant Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Decoagulant Players Market Share by Revenue

2.7.3 Global Decoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Decoagulant Retrospective Market Scenario by Region

3.1 Global Decoagulant Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Decoagulant Global Decoagulant Sales by Region: 2019-2030

3.2.1 Global Decoagulant Sales by Region: 2019-2024

3.2.2 Global Decoagulant Sales by Region: 2025-2030

3.3 Global Decoagulant Global Decoagulant Revenue by Region: 2019-2030

3.3.1 Global Decoagulant Revenue by Region: 2019-2024

3.3.2 Global Decoagulant Revenue by Region: 2025-2030

3.4 North America Decoagulant Market Facts & Figures by Country

3.4.1 North America Decoagulant Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Decoagulant Sales by Country (2019-2030)

3.4.3 North America Decoagulant Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Decoagulant Market Facts & Figures by Country

3.5.1 Europe Decoagulant Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Decoagulant Sales by Country (2019-2030)

3.5.3 Europe Decoagulant Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Decoagulant Market Facts & Figures by Country

3.6.1 Asia Pacific Decoagulant Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Decoagulant Sales by Country (2019-2030)

3.6.3 Asia Pacific Decoagulant Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Decoagulant Market Facts & Figures by Country

3.7.1 Latin America Decoagulant Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Decoagulant Sales by Country (2019-2030)

3.7.3 Latin America Decoagulant Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Decoagulant Market Facts & Figures by Country

3.8.1 Middle East and Africa Decoagulant Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Decoagulant Sales by Country (2019-2030)

3.8.3 Middle East and Africa Decoagulant Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Decoagulant Sales by Type (2019-2030)

4.1.1 Global Decoagulant Sales by Type (2019-2024)

4.1.2 Global Decoagulant Sales by Type (2025-2030)

4.1.3 Global Decoagulant Sales Market Share by Type (2019-2030)

4.2 Global Decoagulant Revenue by Type (2019-2030)

4.2.1 Global Decoagulant Revenue by Type (2019-2024)

4.2.2 Global Decoagulant Revenue by Type (2025-2030)

4.2.3 Global Decoagulant Revenue Market Share by Type (2019-2030)

4.3 Global Decoagulant Price by Type (2019-2030)

5 Segment by Application

5.1 Global Decoagulant Sales by Application (2019-2030)

5.1.1 Global Decoagulant Sales by Application (2019-2024)

5.1.2 Global Decoagulant Sales by Application (2025-2030)

5.1.3 Global Decoagulant Sales Market Share by Application (2019-2030)

5.2 Global Decoagulant Revenue by Application (2019-2030)

5.2.1 Global Decoagulant Revenue by Application (2019-2024)

5.2.2 Global Decoagulant Revenue by Application (2025-2030)

5.2.3 Global Decoagulant Revenue Market Share by Application (2019-2030)

5.3 Global Decoagulant Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Decoagulant Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 Bayer

6.2.1 Bayer Corporation Information

6.2.2 Bayer Description and Business Overview

6.2.3 Bayer Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Bayer Decoagulant Product Portfolio

6.2.5 Bayer Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Boehringer Ingelheim Decoagulant Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Johnson & Johnson

6.4.1 Johnson & Johnson Corporation Information

6.4.2 Johnson & Johnson Description and Business Overview

6.4.3 Johnson & Johnson Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Johnson & Johnson Decoagulant Product Portfolio

6.4.5 Johnson & Johnson Recent Developments/Updates

6.5 Genentech (Roche)

6.5.1 Genentech (Roche) Corporation Information

6.5.2 Genentech (Roche) Description and Business Overview

6.5.3 Genentech (Roche) Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Genentech (Roche) Decoagulant Product Portfolio

6.5.5 Genentech (Roche) Recent Developments/Updates

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Description and Business Overview

6.6.3 AstraZeneca Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.6.4 AstraZeneca Decoagulant Product Portfolio

6.6.5 AstraZeneca Recent Developments/Updates

6.7 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Corporation Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bristol-Myers Squibb Decoagulant Product Portfolio

6.7.5 Bristol-Myers Squibb Recent Developments/Updates

6.8 Aspen

6.8.1 Aspen Corporation Information

6.8.2 Aspen Description and Business Overview

6.8.3 Aspen Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Aspen Decoagulant Product Portfolio

6.8.5 Aspen Recent Developments/Updates

6.9 Lilly

6.9.1 Lilly Corporation Information

6.9.2 Lilly Description and Business Overview

6.9.3 Lilly Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Lilly Decoagulant Product Portfolio

6.9.5 Lilly Recent Developments/Updates

6.10 Otsuka

6.10.1 Otsuka Corporation Information

6.10.2 Otsuka Description and Business Overview

6.10.3 Otsuka Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Otsuka Decoagulant Product Portfolio

6.10.5 Otsuka Recent Developments/Updates

6.11 Pfizer

6.11.1 Pfizer Corporation Information

6.11.2 Pfizer Decoagulant Description and Business Overview

6.11.3 Pfizer Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Pfizer Decoagulant Product Portfolio

6.11.5 Pfizer Recent Developments/Updates

6.12 Daiichi Sankyo

6.12.1 Daiichi Sankyo Corporation Information

6.12.2 Daiichi Sankyo Decoagulant Description and Business Overview

6.12.3 Daiichi Sankyo Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Daiichi Sankyo Decoagulant Product Portfolio

6.12.5 Daiichi Sankyo Recent Developments/Updates

6.13 The Medicines Company

6.13.1 The Medicines Company Corporation Information

6.13.2 The Medicines Company Decoagulant Description and Business Overview

6.13.3 The Medicines Company Decoagulant Sales, Revenue and Gross Margin (2019-2024)

6.13.4 The Medicines Company Decoagulant Product Portfolio

6.13.5 The Medicines Company Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Decoagulant Industry Chain Analysis

7.2 Decoagulant Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Decoagulant Production Mode & Process

7.4 Decoagulant Sales and Marketing

7.4.1 Decoagulant Sales Channels

7.4.2 Decoagulant Distributors

7.5 Decoagulant Customers

8 Decoagulant Market Dynamics

8.1 Decoagulant Industry Trends

8.2 Decoagulant Market Drivers

8.3 Decoagulant Market Challenges

8.4 Decoagulant Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

The Medicines Company

List of Tables

Table 1. Global Decoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Decoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Decoagulant Market Competitive Situation by Manufacturers in 2023

Table 4. Global Decoagulant Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Decoagulant Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Decoagulant Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Decoagulant Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Decoagulant Average Price (USD/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Decoagulant, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Decoagulant, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Decoagulant, Product Type & Application

Table 12. Global Key Manufacturers of Decoagulant, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Decoagulant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decoagulant as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Decoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Decoagulant Sales by Region (2019-2024) & (K Doses)

Table 18. Global Decoagulant Sales Market Share by Region (2019-2024)

Table 19. Global Decoagulant Sales by Region (2025-2030) & (K Doses)

Table 20. Global Decoagulant Sales Market Share by Region (2025-2030)

Table 21. Global Decoagulant Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Decoagulant Revenue Market Share by Region (2019-2024)

Table 23. Global Decoagulant Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Decoagulant Revenue Market Share by Region (2025-2030)

Table 25. North America Decoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Decoagulant Sales by Country (2019-2024) & (K Doses)

Table 27. North America Decoagulant Sales by Country (2025-2030) & (K Doses)

Table 28. North America Decoagulant Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Decoagulant Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Decoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Decoagulant Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Decoagulant Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Decoagulant Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Decoagulant Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Decoagulant Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Decoagulant Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Decoagulant Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Decoagulant Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Decoagulant Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Decoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Decoagulant Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Decoagulant Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Decoagulant Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Decoagulant Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Decoagulant Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Decoagulant Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Decoagulant Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Decoagulant Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Decoagulant Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Decoagulant Sales (K Doses) by Type (2019-2024)

Table 51. Global Decoagulant Sales (K Doses) by Type (2025-2030)

Table 52. Global Decoagulant Sales Market Share by Type (2019-2024)

Table 53. Global Decoagulant Sales Market Share by Type (2025-2030)

Table 54. Global Decoagulant Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Decoagulant Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Decoagulant Revenue Market Share by Type (2019-2024)

Table 57. Global Decoagulant Revenue Market Share by Type (2025-2030)

Table 58. Global Decoagulant Price (USD/Dose) by Type (2019-2024)

Table 59. Global Decoagulant Price (USD/Dose) by Type (2025-2030)

Table 60. Global Decoagulant Sales (K Doses) by Application (2019-2024)

Table 61. Global Decoagulant Sales (K Doses) by Application (2025-2030)

Table 62. Global Decoagulant Sales Market Share by Application (2019-2024)

Table 63. Global Decoagulant Sales Market Share by Application (2025-2030)

Table 64. Global Decoagulant Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Decoagulant Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Decoagulant Revenue Market Share by Application (2019-2024)

Table 67. Global Decoagulant Revenue Market Share by Application (2025-2030)

Table 68. Global Decoagulant Price (USD/Dose) by Application (2019-2024)

Table 69. Global Decoagulant Price (USD/Dose) by Application (2025-2030)

Table 70. Sanofi Corporation Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 73. Sanofi Decoagulant Product

Table 74. Sanofi Recent Developments/Updates

Table 75. Bayer Corporation Information

Table 76. Bayer Description and Business Overview

Table 77. Bayer Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 78. Bayer Decoagulant Product

Table 79. Bayer Recent Developments/Updates

Table 80. Boehringer Ingelheim Corporation Information

Table 81. Boehringer Ingelheim Description and Business Overview

Table 82. Boehringer Ingelheim Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 83. Boehringer Ingelheim Decoagulant Product

Table 84. Boehringer Ingelheim Recent Developments/Updates

Table 85. Johnson & Johnson Corporation Information

Table 86. Johnson & Johnson Description and Business Overview

Table 87. Johnson & Johnson Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 88. Johnson & Johnson Decoagulant Product

Table 89. Johnson & Johnson Recent Developments/Updates

Table 90. Genentech (Roche) Corporation Information

Table 91. Genentech (Roche) Description and Business Overview

Table 92. Genentech (Roche) Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 93. Genentech (Roche) Decoagulant Product

Table 94. Genentech (Roche) Recent Developments/Updates

Table 95. AstraZeneca Corporation Information

Table 96. AstraZeneca Description and Business Overview

Table 97. AstraZeneca Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 98. AstraZeneca Decoagulant Product

Table 99. AstraZeneca Recent Developments/Updates

Table 100. Bristol-Myers Squibb Corporation Information

Table 101. Bristol-Myers Squibb Description and Business Overview

Table 102. Bristol-Myers Squibb Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 103. Bristol-Myers Squibb Decoagulant Product

Table 104. Bristol-Myers Squibb Recent Developments/Updates

Table 105. Aspen Corporation Information

Table 106. Aspen Description and Business Overview

Table 107. Aspen Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 108. Aspen Decoagulant Product

Table 109. Aspen Recent Developments/Updates

Table 110. Lilly Corporation Information

Table 111. Lilly Description and Business Overview

Table 112. Lilly Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 113. Lilly Decoagulant Product

Table 114. Lilly Recent Developments/Updates

Table 115. Otsuka Corporation Information

Table 116. Otsuka Description and Business Overview

Table 117. Otsuka Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 118. Otsuka Decoagulant Product

Table 119. Otsuka Recent Developments/Updates

Table 120. Pfizer Corporation Information

Table 121. Pfizer Description and Business Overview

Table 122. Pfizer Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 123. Pfizer Decoagulant Product

Table 124. Pfizer Recent Developments/Updates

Table 125. Daiichi Sankyo Corporation Information

Table 126. Daiichi Sankyo Description and Business Overview

Table 127. Daiichi Sankyo Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 128. Daiichi Sankyo Decoagulant Product

Table 129. Daiichi Sankyo Recent Developments/Updates

Table 130. The Medicines Company Corporation Information

Table 131. The Medicines Company Description and Business Overview

Table 132. The Medicines Company Decoagulant Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 133. The Medicines Company Decoagulant Product

Table 134. The Medicines Company Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Decoagulant Distributors List

Table 138. Decoagulant Customers List

Table 139. Decoagulant Market Trends

Table 140. Decoagulant Market Drivers

Table 141. Decoagulant Market Challenges

Table 142. Decoagulant Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Decoagulant

Figure 2. Global Decoagulant Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Decoagulant Market Share by Type in 2023 & 2030

Figure 4. Platelet Aggregation Inhibitors (PAI) Product Picture

Figure 5. Low-Molecular-Weight Heparin (LMWH) Product Picture

Figure 6. Direct Thrombin Inhibitor (DTI) Product Picture

Figure 7. Direct Factor Xa Inhibitors (DFXa) Product Picture

Figure 8. Vitamin K Antagonists (VKA) Product Picture

Figure 9. Others Product Picture

Figure 10. Global Decoagulant Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Decoagulant Market Share by Application in 2023 & 2030

Figure 12. VTE

Figure 13. ACS/MI

Figure 14. AF

Figure 15. Others

Figure 16. Global Decoagulant Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Decoagulant Market Size (2019-2030) & (US$ Million)

Figure 18. Global Decoagulant Sales (2019-2030) & (K Doses)

Figure 19. Global Decoagulant Average Price (USD/Dose) & (2019-2030)

Figure 20. Decoagulant Report Years Considered

Figure 21. Decoagulant Sales Share by Manufacturers in 2023

Figure 22. Global Decoagulant Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Decoagulant Players: Market Share by Revenue in 2023

Figure 24. Decoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Decoagulant Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Decoagulant Sales Market Share by Country (2019-2030)

Figure 27. North America Decoagulant Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Decoagulant Sales Market Share by Country (2019-2030)

Figure 31. Europe Decoagulant Revenue Market Share by Country (2019-2030)

Figure 32. Germany Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Decoagulant Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Decoagulant Revenue Market Share by Region (2019-2030)

Figure 39. China Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Decoagulant Sales Market Share by Country (2019-2030)

Figure 50. Latin America Decoagulant Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Decoagulant Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Decoagulant Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. UAE Decoagulant Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Decoagulant by Type (2019-2030)

Figure 60. Global Revenue Market Share of Decoagulant by Type (2019-2030)

Figure 61. Global Decoagulant Price (USD/Dose) by Type (2019-2030)

Figure 62. Global Sales Market Share of Decoagulant by Application (2019-2030)

Figure 63. Global Revenue Market Share of Decoagulant by Application (2019-2030)

Figure 64. Global Decoagulant Price (USD/Dose) by Application (2019-2030)

Figure 65. Decoagulant Value Chain

Figure 66. Decoagulant Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-16160

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-10G2665

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions